ORIC Pharmaceuticals, Inc.
ORIC
$12.04
-$0.18-1.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.27% | -12.85% | -23.89% | -30.56% | -26.96% |
| Total Depreciation and Amortization | 10.21% | 12.95% | 12.63% | 10.38% | 7.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 87.75% | 95.75% | 99.59% | 66.18% | 33.38% |
| Change in Net Operating Assets | -377.39% | -540.89% | -405.63% | 146.06% | -59.82% |
| Cash from Operations | 1.50% | -7.04% | -20.56% | -20.75% | -31.48% |
| Capital Expenditure | 40.07% | 31.38% | -58.69% | -79.26% | -39.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -731.59% | -8,370.29% | 115.46% | 191.92% | 154.81% |
| Cash from Investing | -768.70% | -27,596.63% | 113.98% | 190.18% | 151.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 95.45% | 94.90% | 7.25% | -99.16% | 47.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,326.79% | -1,318.34% | -288.17% | 38.73% | 25.99% |
| Cash from Financing | 93.81% | 93.27% | 6.87% | -99.27% | 47.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -138.14% | -69.78% | 148.34% | -169.51% | 182.94% |